FilingReader Intelligence

Jointown subsidiary's industry fund completes registration

November 11, 2025 at 09:31 AM UTCBy FilingReader AI

Jointown Pharmaceutical Group Co., Ltd. announced that its controlled subsidiary, Beijing Jiuzhou Zhongchuang Technology Incubator Co., Ltd., has completed the registration of the Wuhan Chuchang Tongda Industry Investment Fund Partnership (Limited Partnership) with the Asset Management Association of China. The fund received its Private Investment Fund Registration Certificate on November 10, 2025.

Beijing Jiuzhou Zhongchuang Technology Incubator Co., Ltd. committed an investment of 10 million yuan to the industry fund, representing 7.14% of the fund's total subscribed capital. This strategic investment aims to bolster the company’s industry incubator development and expand its footprint in emerging sectors such as innovative medical devices and artificial intelligence in medicine.

The industry fund is managed by Beijing Chuchang Private Equity Fund Management Co., Ltd. and utilizes China Merchants Bank Co., Ltd. as its custodian. Jointown Pharmaceutical Group reiterated its commitment to closely monitor the fund's progress and ensure timely information disclosure, urging investors to be aware of potential investment risks.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Jointown Pharmaceutical Group publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →